|
|
||||||||
,1

* Schools of Animal Studies and Veterinary Science, University of Queensland, St. Lucia 4072, Brisbane, Australia
Department of Animal and Poultry Science, and
Department of Clinical Studies, University of Guelph, Ontario, N1G 2W1, Canada
1 Corresponding author: npurdie{at}uoguelph.ca
| ABSTRACT |
|---|
|
|
|---|
Key Words: amino acid acetate arterial infusion milk composition
| INTRODUCTION |
|---|
|
|
|---|
When arterial AA concentrations were increased 2-to 3-fold for 10 h in cows fed a diet of 16% CP and 1.7 Mcal of NEL/kg, milk protein yield only increased 13% (Cant et al., 2001). Similarly, milk lactose yield was not affected by a 1.8-fold elevation of plasma glucose concentration for 10 h (Cant et al., 2002). These and similar observations of small responses in milk component yields to large changes in precursor concentrations in vivo led to the conclusion that, in general, milk component secretion is insensitive to precursor concentrations (Cant et al., 2003), which means that the Km for utilization of the precursor must be substantially lower than the normal physiological concentration of the precursor. This conclusion lies in contrast to estimates of Km that have been obtained from fitting the concentration dependencies of milk fat and lactose synthesis in vitro. In culture, mammary cells exhibit Km values for biosynthetic use of acetate and glucose very similar to the physiological concentrations of the 2 precursors (Forsberg et al., 1984, 1985). The whole-cow simulation model of Baldwin (1995) assigns a Km of 1.8 mM to the synthesis of milk fat from plasma acetate and a Km of 3.0 mM to the synthesis of lactose from plasma glucose. These Km values are equal to the reference concentrations of acetate and glucose, respectively, and would yield predictions of relatively large increases in fat and lactose yields in response to doubling of precursor concentrations.
The short-term effects of acetate concentration on milk fat synthesis in vivo have not been extensively studied. Over several days, 40 g of acetate/h infused into the rumen of cows stimulated yields of protein, fat, lactose, and total milk by approximately 12% (Rook and Balch, 1961). Compared with an isoenergetic infusion of intraruminal propionate, intraruminal acetate at 6 g/h for 10 d into goats increased the yield of milk fat by 36% with no effect on yield of protein or milk volume (Lough et al., 1983). However, in the short-term, Linzell (1967) reported that intravenous acetate infusion for 3 h into a fasted goat to restore the prefasting concentration of acetate did not affect yield of milk or fat. To establish the sensitivities of milk fat yield and mammary acetate utilization to circulating acetate concentration, we infused lactating cows with sodium acetate or saline in an external iliac artery feeding one udder half.
Synthesis of milk proteins in the mammary glands is an energy-demanding process, and the possibility exists that a low sensitivity to AA supply may be the result of an inadequate supply of metabolic energy. A second objective of our work was to reexamine short-term responses to elevated AA concentrations when acetate was also given to provide a supplemental source of energy. Third, given that the profile of AA available in circulation determines its quality for protein synthesis, we compared responses to 2 different profiles of infused AA, one based on the rumen microbial protein profile and one based on the milk protein profile.
| MATERIALS AND METHODS |
|---|
|
|
|---|
After catheterization surgery, cows were fed a TMR (Table 1
) of alfalfa haylage and a concentrate mixed in a 60:40 proportion, respectively, by weight. Hand-mixed TMR was fed ad libitum at each milking with refusals removed and weighed at 0730 h to calculate DMI. A grab sample of the TMR was acquired a number of times during the experiment for analysis. Each consignment of concentrate and each load of haylage were sampled for analysis.
|
The experiment was designed as a 3 x 2 factorial within a 6 x 6 Latin square, with 3 AA treatments: 0 g/h, 30 g/h in the profile of rumen microbes (Clark et al., 1992), and 30 g/h in the profile of milk proteins (Hambraeus, 1982), and 2 acetate treatments: 0 and 40 g/h. Due to time constraints imposed by catheter patency, only 2 cows were subjected to the experiment at any one time. Thus, the 6 x 6 Latin square was accomplished in 3 consecutive, incomplete Latin squares. Infusion and sampling protocols were as previously used (Cant et al., 2001). Each period consisted of 10 h of continuous arterial infusion daily, followed by 14 h of rest.
Solutions were prepared the night before infusion in 3-L batches. They were: 9 g/L of saline, 110 g/L of AA in the microbial profile (Table 2
), 110 g/L of AA in the milk profile (Table 2
), 200 g/L of sodium acetate, 200 g/L of sodium acetate + 110 g/L of microbial AA, and 200 g/L of sodium acetate + 110 g/L of milk AA. The Gln, Asn, and Tyr of the 2 AA profiles were replaced with molar equivalents of Glu, Asp, and Phe, respectively. Individual AA, purchased from USBiochemical (Cleveland, OH) and Sigma Chemical Co. (Oakville, Ontario, Canada), were added to 2.5 L of Milli Q Ultra-pure water [Millipore (Canada) Ltd., Mississauga, Ontario, Canada] containing 30 g of NaOH in the order listed in Table 2
; each was dissolved before adding the next. All infusates were adjusted to pH 7.4 by adding either HCl or NaOH, subjected to a density determination by weighing 1-mL aliquots 5 times, filtered through a 0.22-µm cellulose acetate filter, and stored in 4-L autoclaved, polypropylene bottles. The bottles were sealed and refrigerated overnight and were warmed before infusion.
|
Analytical Procedures
Milk samples were analyzed by infrared spectroscopy for protein, fat, and lactose content (AOAC, 1996). The 3 plasma samples from each blood vessel were analyzed individually for PAH and pooled for analysis of glucose, triacylglycerol, NEFA, and acetate concentrations by spectrophotometry, and for AA by reversed-phase HPLC, as previously described (Cant et al., 2001). Infusates were also analyzed for PAH and acetate accordingly.
Iliac plasma flow (IPF) at each of the 3 sampling timepoints was calculated from PAH analyses as
![]() |
Mammary extraction of a plasma metabolite, calculated as the quotient of its arteriovenous difference and arterial concentration, is a consequence of both transmembrane transport and plasma flow. As an alternative to calculating extraction, then, the product of the first-order rate constant for capillary uptake (k) and the total volume of perfused capillaries (Volcap·Ncap) was calculated as k·Volcap·Ncap = –ln(1 – extraction) x IPF, according to Cant and McBride (1995).
Statistical Analyses
Variance in each observation (Yijklm) was analyzed by using the following model, with the GLM procedure of SAS Institute (2000):
![]() |
where µ... = mean, sqi = ith square effect (1 = 1 to 3), cowj(i) = jth cow effect within each ith square (j = 1 to 6), perk = kth period effect (k = 1 to 6), aal = lth AA infusion effect (1 = 1 to 3), acm = mth acetate infusion effect (m = 1 to 2), and
ijklm = error.
Effect of the AA profile was evaluated with an orthogonal contrast between lth AA treatments 2 and 3. Significances of effects were declared at P
0.05 and tendencies were declared at 0.05 > P
0.15.
To test for carryover of treatment effects from one period to the next, the following ANOVA model was used:
![]() |
where µ... = true grand mean, sqi = ith square effect (1 = 1 to 3), cowj(i) = jth cow effect within each ith square (j = 1 to 6), perk = kth period effect (k = 1 to 6), prevtrtl = lth previous treatment effect (1 = 1 to 6), and
ijklm = error.
No carryover effects were detected for any of the observed variables.
| RESULTS |
|---|
|
|
|---|
Effects of AA Infusion
The only effect of AA infusion on milk components from the infused udder half was a tendency for an 8% increase in protein yield (Table 3
). Because milk yield remained unchanged, protein percentage was greater following AA infusion. The profile of the AA infusate made no difference in milk components.
|
|
|
Plasma acetate concentrations were elevated 33% in the general arterial circulation and 123% in the close arterial circulation of the infused udder half (Table 4
). Extraction of arterial acetate by the infused udder half was decreased by the infusion but the k·Volcap·Ncap product was not actually affected, so the 123% increase in mammary acetate uptake was due entirely to the increase in arterial acetate concentration. Arterial glucose and insulin concentrations were elevated by acetate infusion (Table 4
), the k·Volcap·Ncap tended to be increased and so mammary uptake of glucose increased 18%. There was no change in BHBA, triacylglycerol, or LCFA supply or utilization by the mammary glands (Table 4
).
During acetate infusion, there were decreased concentrations in the arterial circulation of Pro, Ser, and Gly and tendencies for decreases in Thr, Arg, citrulline (Cln), and Ala (Table 5
). Isoleucine concentration tended to increase with acetate. Close arterial concentrations were similarly affected. Proline, Ser, and Gly decreased, Lys, Thr, Arg, and Cln tended to decrease, and Ile tended to increase. Extraction of the close arterial Ile and Leu decreased and extraction of Cln increased. The only AA uptake affected by acetate infusion was a 23% increase in Cln uptake.
| DISCUSSION |
|---|
|
|
|---|
Aside from the capture in milk protein, 2 other marginal efficiency measures can be calculated from the mammary arteriovenous difference data. One measure is the extraction of arterially infused AA on the first pass through the mammary glands, which was calculated as (exiAi – exoAo)/(Ai – Ao), where exi and exo are the arteriovenous extraction percentages on the infused and opposite sides, respectively, and Ai and Ao are the respective arterial concentrations. Because exo was not measured, it was estimated from the slope of the change in extraction percentages over the change in arterial AA concentrations between control and AA infusions as exc + (Ao – Ac)(exi – exc)/(Ai – Ac), where exc and Ac are the extraction percentages and arterial concentrations during control infusions. First-pass extractions of infused AA ranged from –89 to 98% (Table 6
) and for many AA tended to be lower than extraction of the basal arterial concentration. This decline in percentage extraction of AA as arterial concentrations increase has been noted previously (Hanigan et al., 1992; Tesseraud et al., 1992) and is likely a consequence of the bidirectional transport of AA across the mammary glands. Amino acids taken into mammary cells have a greater chance of returning to the circulation when the proportion incorporated into protein is decreasing (Bequette et al., 2001), as was occurring during AA infusion in this study. Net first-pass extraction of the entire infusate, on a molar basis, averaged 21% for the microbial AA profile and 22% for the milk AA profile.
|
In addition to changes in mammary AA utilization, AA infusion caused insulin concentrations to increase in arterial plasma and stimulated the mammary uptake of the energy metabolites glucose and acetate. Insulin stimulates milk protein secretion when administered continuously over several days (Griinari et al., 1997), so the possibility exists that the small increase in milk protein yield observed over 10 h was due to this hormonal effect, and not to the AA per se. However, short-term infusions of insulin have not resulted in any detectable changes in mammary AA utilization (Laarveld et al., 1981; Tesseraud et al., 1992). Nor does insulin appear to influence glucose or acetate utilization by mammary tissue in the short term (Laarveld et al., 1985). Insulin concentration was most likely increased in response to elevated glucose concentrations, as well as the increase in AA concentration, because both are potent secretagogues of the hormone. The glucose and acetate concentrations likely increased as products of disposal of the 60% of the infused AA not used by mammary tissue. The approximately 20% increase in k·Vol-cap·Ncap products for glucose and acetate clearance by the mammary glands (Table 4
) remains unexplained.
Few differences between the microbial and milk AA profiles were observed. The milk AA profile infused was substantially greater in Glu and Pro content and lower in Asp, Ala, Gly, and Arg (Tables 2
and 6
). The difference between infusates in Pro content resulted in a greater Pro concentration in the general circulation of cows infused with the milk AA profile but none of the other differences were manifest (Table 5
). In the close arterial plasma, the Pro, Asp, and Gly differences between infusates were retained. These AA are not generally considered to be important to milk synthesis, although the excessive uptake of Arg by the mammary glands for synthesis of the Pro and Glu of milk protein has prompted some investigation of Pro responses. The main effect of postruminal Pro supplementation (80 g/d) of cows appears to be a disproportionately large increase in milk fat yield (Bruckental et al., 1991), which has been shown to be a symptom of an AA imbalance rather than a corrected deficiency (Weekes et al., 2006). Arteriovenous differences of Arg were reduced during Pro infusion (Bruckental et al., 1991) and a similar sparing of the conversion of Arg to Pro in the mammary glands and elsewhere in the body may have occurred in this experiment such that Arg concentrations rose in both the general and the close arterial plasma with the milk AA profile compared with the microbial AA profile (Table 5
), despite being infused at a slower rate. The branched-chain AA also tended to be greater in both infused and noninfused arteries with the milk AA profile compared with the microbial AA profile. This effect might be indicative of differences in hepatic AA utilization that consume little Val, Ile, and Leu. None of the differences in AA concentrations between infusate profiles had an effect on yield or composition of milk.
Sensitivity to Acetate Concentration
First-pass extraction by the infused udder half of the 645 mmol/h acetate infused into one external iliac artery was calculated from the difference between extraction percentages on the treatments with and without acetate, as for the AA above, to be 65%. The proportion of infused acetate that was taken up by the infused udder half, on a net basis, was 98%. Again, both these values are overestimates because of a fraction of blood in the external iliac artery that does not flow to the mammary glands. Nevertheless, it is apparent that a very high proportion of the acetate infusion was used by the mammary glands. In addition, because there was no change with acetate infusion in the k·Volcap·Ncap product representing clearance of plasma acetate by the mammary glands, the uptake of acetate can be said to be a direct consequence of the arterial acetate concentration. More specifically, the hypothesis holds that acetate uptake follows first-order, mass-action kinetics. This hypothesis was also upheld by close arterial glucose infusions during which IPF decreased by 16% but the first-order rate constant for mammary acetate uptake did not change, so acetate uptake decreased (Cant et al., 2002).
When glucose infusion caused acetate uptake by the mammary glands to decrease, there was no concomitant decrease in milk fat yield (Cant et al., 2002). Likewise, the increase in acetate uptake induced by acetate infusion in this experiment caused no significant change in milk fat yield. Linzell (1967) also reported no change in milk or fat yield of a fasted goat infused for 3 h with acetate. In a preliminary experiment, acetate infusion at graded levels up to 36 g/h into the external iliac artery of 4 cows for 10 h did not affect milk fat yields or percentages (Maas et al., 1995). The evidence is strong that fat yield is not sensitive to acetate concentrations or uptake by the mammary glands. In this experiment we add evidence to indicate that net BHBA and LCFA disappearance across the mammary glands is also not affected by a high acetate concentration. Thus, the additional acetate does not appear to induce a change in the use of other fat precursors.
The implication of no effect of acetate concentration, for mechanistic modeling of milk synthesis using Michaelis-Menten-type equations, is that the Km value should be set much lower than the physiological concentration of plasma acetate. This conclusion conflicts with the Km of 1.2 mM estimated from conversions of [1-14C]acetate to fatty acids by mammary tissue incubated in vitro (Forsberg et al., 1984). However, Baldwin (1995) reported that the simulation model MOLLY, with a Km for acetate conversion to milk triacylglycerol of 1.8 mM, predicted an approximately 40% increase in milk fat yield when blood acetate concentration was increased over the range we investigated, from 1.3 to 3.3 mM. A Km one order of magnitude smaller (i.e., 0.18 mM) would yield an 8% increase in predicted milk fat yield. The Baldwin (1995) model was designed to describe longer-term responses to dietary perturbations, not within a day, as in this experiment. Longer-term infusions of acetate have indeed resulted in increased milk fat yields (Rook and Balch, 1961; Lough et al., 1983). Our suggestion is that the Vmax for milk fat synthesis from acetate must increase to bring about this response. The Vmax represents enzymatic capacity, which would be expected to increase over the course of a few days, and not within the 10-h timeframe of our experiment. The combination of an increase in Vmax for each increase in acetate concentration over the long term could generate an aggregate response curve that appears very similar to a saturating Michaelis-Menten-type curve (Cant et al., 1999). Thus, the Km that is used for long-term simulations of mammary responses to circulating concentrations of milk precursors may express a different level of aggregation than the short-term Km and the two should not be confused.
If acetate uptake increased 123% but milk fat yield and BHBA and LCFA uptakes were not significantly affected, where did the additional acetate go? There is a time delay between uptake of acetate from the blood plasma and output in milk of the fat synthesized from it. Thus, some of the infused acetate may have been incorporated into milk fat that was secreted after our 10-h infusion period. Fat secreted during the 14-h milking interval after acetate infusions ceased was 13.6 g higher than after the other infusions ceased, which, if 40% by weight of the fat is synthesized from acetate, could account for only 151 mmol of acetate uptake. Even in conjunction with 105 mmol of acetate estimated to have been used in additional milk fat synthesis during the infusion period, most of the 6,392 mmol of uptake remains unaccounted for. Aside from fat, the other main product of acetate utilization in mammary tissue is CO2 (Scott et al., 1976; Forsberg et al., 1984) in oxidative phosphorylation of adenosine nucleosides. But that would generate a lot of ATP whose use must be explained.
We have hypothesized in the past that the mammary glands exert control over the local rate of blood flow to match ATP production with its utilization (Cant and McBride, 1995). According to this hypothesis, it was predicted that IPF would decrease by 32% during close arterial infusion of 90 g/h glucose, and it was actually observed to decrease by 16% (Cant et al., 2002). Simulations with the mammary model described by Cant et al. (2003), from concentrations of metabolites observed in this experiment, yield a predicted decrease in IPF to 322 L/h to maintain ATP balance on the acetate infusion treatment, whereas it actually remained at 505 L/h (Table 4
). The data may be sufficient to disprove the hypothesis, although without a change in plasma flow there remains a problem of energy balance across the udder half to be resolved.
In addition to faster uptake of acetate that was not incorporated into a milk component, the high acetate concentration also stimulated uptake of glucose by 18% but lactose yields in milk were not affected. Presumably, then, the additional glucose was oxidized to yield ATP. Forsberg et al. (1985) observed a dramatic increase in rates of glucose oxidation by slices of mammary tissue incubated in vitro with increasing concentrations of acetate. Between the concentrations of 1.3 and 3.3 mM observed in our experiment, production of 14CO2 from [1-14C]glucose increased approximately 25% and, from [2-14C]glucose, approximately 10% (Forsberg et al., 1985). The particular stimulation of glucose utilization in the pentose phosphate cycle implicates faster NADPH removal in fat synthesis from acetate yet, although we observed a similar increase in mammary glucose oxidation at the elevated acetate concentration, no change in milk fat synthesis was apparent. The energy balance problem and the stimulation of glucose oxidation can both be resolved if a good portion of the acetate that disappeared between artery and vein was taken up into adipose cells of the udder half and converted to triacylglycerol. An udder half may contain 1 to 3 kg of adipose tissue that responds in size to the nutritional status of the cow (Gibb et al., 1992) and, if it behaves similarly to subcutaneous depots, is more lipogenic in late lactation than early (McNamara and Hillers, 1986). In addition, when acetate is the primary substrate of lipogenesis in ruminant adipose tissue and glucose is used only for synthesis of the glycerol backbone of stored lipids (Vernon, 1980), the glucose we infused previously (Cant et al., 2002), in contrast to acetate here, would not have been taken up into mammary adipose and an IPF response was induced.
| CONCLUSIONS |
|---|
|
|
|---|
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
Received for publication June 28, 2007. Accepted for publication September 17, 2007.
| REFERENCES |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |